Stoke Therapeutics (STOK) Asset Utilization Ratio: 2022-2025
Historic Asset Utilization Ratio for Stoke Therapeutics (STOK) over the last 3 years, with Sep 2025 value amounting to 0.55.
- Stoke Therapeutics' Asset Utilization Ratio rose 891.20% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year increase of 891.20%. This contributed to the annual value of 0.15 for FY2024, which is 303.44% up from last year.
- Stoke Therapeutics' Asset Utilization Ratio amounted to 0.55 in Q3 2025, which was up 9.31% from 0.51 recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Asset Utilization Ratio ranged from a high of 0.56 in Q1 2025 and a low of 0.05 during Q4 2022.
- Over the past 3 years, Stoke Therapeutics' median Asset Utilization Ratio value was 0.06 (recorded in 2024), while the average stood at 0.19.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first dropped by 2.61% in 2024, then soared by 891.20% in 2025.
- Stoke Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.05 in 2022, then climbed by 26.28% to 0.06 in 2023, then spiked by 120.48% to 0.13 in 2024, then surged by 891.20% to 0.55 in 2025.
- Its Asset Utilization Ratio stands at 0.55 for Q3 2025, versus 0.51 for Q2 2025 and 0.56 for Q1 2025.